| scholarly article | Q13442814 |
| P50 | author | Jean-Denis Docquier | Q28324616 |
| Gabriele Cruciani | Q56858982 | ||
| Donatella Tondi | Q57975565 | ||
| Antonio Quotadamo | Q60620220 | ||
| Jesus Blazquez | Q68273789 | ||
| P2093 | author name string | Francesca Spyrakis | |
| Alberto Venturelli | |||
| Simon Cross | |||
| Davide Farina | |||
| Maria Paola Costi | |||
| Ana Isabel Prieto | |||
| Matteo Santucci | |||
| Filomena De Luca | |||
| Claudia Ibacache | |||
| P2860 | cites work | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Q24617818 |
| Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis | Q24674712 | ||
| Boron chemicals in diagnosis and therapeutics | Q27006075 | ||
| The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase | Q27620652 | ||
| Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase | Q27632621 | ||
| Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases † , ‡ | Q27644490 | ||
| Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy | Q27648872 | ||
| Structural study of phenyl boronic acid derivatives as AmpC β-lactamase inhibitors | Q27661425 | ||
| Fragment-guided design of subnanomolar -lactamase inhibitors active in vivo | Q27674310 | ||
| Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC -Lactamases | Q27676626 | ||
| Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative | Q27684016 | ||
| Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum β-Lactamase CTX-M-96 | Q27701698 | ||
| Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design | Q27766045 | ||
| A computational procedure for determining energetically favorable binding sites on biologically important macromolecules | Q30406755 | ||
| Accelerating resistance, inadequate antibacterial drug pipelines and international responses | Q30413178 | ||
| Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase | Q30414976 | ||
| Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field | Q30966913 | ||
| Pharmacophore modeling, docking studies, and synthesis of novel dipeptide proteasome inhibitors containing boron atoms | Q84429277 | ||
| A Pipeline To Enhance Ligand Virtual Screening: Integrating Molecular Dynamics and Fingerprints for Ligand and Proteins. | Q50856972 | ||
| A Statistical Survey on the Binding Constants of Covalently Bound Protein-Ligand Complexes. | Q51612874 | ||
| A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application. | Q51919227 | ||
| Aromatic rings act as hydrogen bond acceptors | Q67936192 | ||
| Rapid beta-lactamase testing in bacteroides | Q72100419 | ||
| Structural and Functional Aspects of Class A Carbapenemases | Q33604862 | ||
| New β-lactamase inhibitors: a therapeutic renaissance in an MDR world | Q33622976 | ||
| Molecular basis of NDM-1, a new antibiotic resistance determinant | Q34009443 | ||
| Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding. | Q34045301 | ||
| Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases | Q34045460 | ||
| CAU-1, a subclass B3 metallo-beta-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. | Q34109198 | ||
| Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases | Q34335278 | ||
| Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers | Q34498607 | ||
| Rapid detection of antibiotic-resistant organism carriage for infection prevention | Q34567314 | ||
| Laboratory detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates and two confirmation techniques | Q34596627 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| The changing epidemiology of resistance | Q34997021 | ||
| Isozyme-specific ligands for O-acetylserine sulfhydrylase, a novel antibiotic target | Q35027753 | ||
| Targeting cystalysin, a virulence factor of treponema denticola-supported periodontitis | Q35116929 | ||
| Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. | Q35166033 | ||
| Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii | Q35689369 | ||
| Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study | Q35764780 | ||
| Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design | Q36644892 | ||
| Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment? | Q36845890 | ||
| Binding of small-molecule ligands to proteins: "what you see" is not always "what you get". | Q37372747 | ||
| Has the era of untreatable infections arrived? | Q37578902 | ||
| Proliferation and significance of clinically relevant β-lactamases | Q38076454 | ||
| The inhibition of extended spectrum β-lactamases: hits and leads | Q38158054 | ||
| Theory and applications of covalent docking in drug discovery: merits and pitfalls | Q38336673 | ||
| Detection of AmpC β Lactamases in Gram-negative Bacteria | Q38556927 | ||
| Synthesis and Applications of Boronic Acid-Containing Polymers: From Materials to Medicine. | Q38586413 | ||
| A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens | Q38615904 | ||
| New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogens. | Q39133411 | ||
| Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore | Q40972127 | ||
| Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses | Q41571076 | ||
| Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose | Q41940976 | ||
| Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates | Q41983307 | ||
| Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N132G in the Conserved SDN Motif | Q42319612 | ||
| Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa | Q42612014 | ||
| A standard numbering scheme for the class A beta-lactamases | Q42861944 | ||
| Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa | Q42910111 | ||
| Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. | Q46003957 | ||
| Carbapenem-resistant Enterobacteriaceae, long-term acute care hospitals, and our distortions of reality. | Q46262114 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | boronic acid | Q335768 |
| biological profile | Q118125750 | ||
| P304 | page(s) | 17716 | |
| P577 | publication date | 2017-12-18 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases | |
| P478 | volume | 7 |
| Q90662878 | 4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases |
| Q92728030 | Forecasting from phenotypic testing to an antimicrobial stewardship strategy: Does the time to positivity of a blue-carba test predict the meropenem susceptibility level among carbapenemase producers? |
| Q60049273 | In silico identification and experimental validation of hits active against KPC-2 β-lactamase |
| Q50093207 | Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. |
| Q90419283 | Phenylboronic Acids Probing Molecular Recognition against Class A and Class C β-lactamases |
| Q59830619 | Targeting Metalloenzymes for Therapeutic Intervention |
| Q98164385 | Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases |
| Q93166853 | X-ray Crystallography Deciphers the Activity of Broad-Spectrum Boronic Acid β-Lactamase Inhibitors |
Search more.